Trials / Conditions / Refractory Pediatric AML
Refractory Pediatric AML
3 registered clinical trials studyying Refractory Pediatric AML — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Withdrawn | ELU001 in Pediatric Subjects Who Have Relapsed and/or Refractory CBFA2T3-GLIS2-positive AML NCT05622591 | Elucida Oncology | Phase 1 |
| Recruiting | Vyxeos® With Clofarabine for Pediatric AML NCT07156435 | Princess Maxima Center for Pediatric Oncology | Phase 1 |
| Unknown | Genomics-Based Target Therapy for Children With Relapsed or Refractory Malignancy NCT02638428 | Samsung Medical Center | Phase 2 |